Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta.

AUTOR(ES)

Yamanaka, H I

RESUMO

A humoral cytotoxic protein that is spontaneously produced by a cloned human lymphoblastoid cell line (K160b) was partially purified by a simple three-step column chromatography procedure and NaDodSO4/polyacrylamide gel electrophoresis. Proteins were electrically blotted onto a polyvinylidene difluoride membrane, and a band of the cytotoxic protein was excised after staining with Coomassie brilliant blue. Direct analysis of the amino acid sequence of this protein showed the primary structure of its N-terminal region was identical to that of natural tumor necrosis factor type beta (TNF-beta). The 24-kDa molecular mass of the cytotoxic protein, determined by NaDodSO4/PAGE, and its elution profiles from various types of columns correlated with those of natural TNF-beta. Specific activity of the cytotoxicity, standardized with recombinant TNF-beta, was comparable to that of the purified factor. However, polyclonal antiserum to recombinant TNF-beta failed to react with the purified factor. Since recombinant TNF-beta, when used in patients, causes unacceptable side effects, which may be due to absence of glycosylation, the cell line K160b could be a useful source of natural TNF-beta for clinical trials.

Documentos Relacionados

• Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.
• B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor.
• Single cell studies on the role of B-cell stimulatory factor 1 in B-cell activation.
• Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.
• Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.